4.8 Editorial Material

The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support

期刊

CANCER CELL
卷 39, 期 3, 页码 288-293

出版社

CELL PRESS
DOI: 10.1016/j.ccell.2021.01.004

关键词

-

资金

  1. F. Hoffmann-La Roche Ltd.
  2. ETH Zurich
  3. University of Zurich
  4. University Hospital Zurich
  5. University Hospital Basel
  6. Biobank team from the Department of Dermatology
  7. Biobank and Tumor Genomic Profiling team of the Department of Pathology and Molecular Pathology at The University Hospital Zurich
  8. Biobank and Ovarian Cancer Research at the Department of Biomedicine, University of Basel
  9. Clinical Trials Center (CTC) Zurich
  10. Clinical Trials Unit (CTU) Basel

向作者/读者索取更多资源

The Tumor Profiler Study combines a prospective diagnostic approach with an exploratory strategy to assess the relevance of in-depth tumor profiling in supporting clinical decision-making and improving the biological understanding of the disease.
The application and integration of molecular profiling technologies create novel opportunities for personalized medicine. Here, we introduce the Tumor Profiler Study, an observational trial combining a prospective diagnostic approach to assess the relevance of in-depth tumor profiling to support clinical decision-making with an exploratory approach to improve the biological understanding of the disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据